Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug | Bentham Science
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
New therapeutic avenues in ulcerative colitis: thinking out of the box | Gut
Prokinetic Drugs A gastroprokinetic agent, gastrokinetic, or prokinetic, is a type of drug which enhances gastrointestinal motility by increasing the frequency. - ppt video online download
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease - Gastroenterology Clinics
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Treatment algorithm of active ulcerative colitis. 5-ASA,... | Download Scientific Diagram
The long journey of salicylates in ulcerative colitis: The past and the future - ScienceDirect
Mechanism of Action of Aminosalicylates - YouTube
Aspirin Mechanism of Action. | Download Scientific Diagram
5-aminosalicylates [TUSOM | Pharmwiki]
Mechanism of Action of Aminosalicylates
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases | Pharmacology
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Frontiers | Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications | Immunology
Oxidized 5-aminosalicylic acid activates Nrf2-HO-1 pathway by covalently binding to Keap1: Implication in anti-inflammatory actions of 5-aminosalicylic acid - ScienceDirect
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor - ScienceDirect
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD. - ppt download
IJMS | Free Full-Text | Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways | HTML
Carcinogenesis in Ulcerative Colitis | IntechOpen
Frontiers | Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications | Immunology
5-ASA | IBD Clinic
Ulcerative Colitis: Achieving and Maintaining Remission
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
PPARgamma as a new therapeutic target in inflammatory bowel diseases. - Abstract - Europe PMC
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology